November 11, 2025 In Memoriam: C-Path Remembers Dr. Gil L’Italien’s Legacy of Science, Compassion, and Collaboration Critical Path Institute is deeply saddened by the passing of Dr. Gilbert L’Italien, or Gil to those who knew him...
November 3, 2025 Celebrating a Decade of Impact: Critical Path for Parkinson’s 10-Year Impact Report Now Available Critical Path for Parkinson’s (CPP), a global public-private partnership led by C-Path...
October 30, 2025 Rare/Orphan and Pediatric Disease Program Webinar: Addressing the Lack of Standardized Laboratory Reference Ranges in Neonatal Trials: Pilot GUI Launch C-Path's International Neonatal Consortium hosts the webinar, "Addressing the Lack of Standardized..."
October 22, 2025 C-Path’s Romero Joins BIO from the BAYOU Podcast: How Collaboration is Transforming Biotech and Drug Drug Development — Inside Critical Path Institute C-Path CEO Klaus Romero recently joined the BIO from the BAYOU Podcast for a guest appearance on the episode...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 14, 2025 Critical Path Institute to be Honored with Reagan-Udall Foundation Innovation Award Award honors regulatory science advances with measurable public health impact; ceremony December 9, 2025, Willard...
October 14, 2025 C-Path Q3 2025 Newsletter This year marks a historic milestone for C-Path as we celebrate 20 years of advancing regulatory science...
October 7, 2025 C-Path CEO Romero Featured in Scientific American Feature The piece explores the concept of healthspan — the years of life lived free from serious disease — a topic gaining momentum...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...